Protecting microRNAs from RNase degradation with steric DNA nanostructures

H Qian1,2, C Y Tay1,3,4, M I Setyawati1

  • 1Department of Chemical and Biomolecular Engineering , National University of Singapore , 4 Engineering Drive 4 , Singapore 117585 , Singapore . Email: cheltwd@nus.edu.sg ; ; Tel: +65 6516 7262.

Chemical Science
|April 29, 2017
PubMed

Insights

Researchers developed a DNA nanostructure to protect tumor-suppressive microRNAs from degradation, enabling effective delivery for potential colorectal cancer therapy. This novel approach overcomes a key challenge in microRNA-based treatments.

Area of Science:

  • Biotechnology and Nanomedicine
  • Molecular Biology and Genetics
  • Oncology and Cancer Therapeutics

Background:

  • Tumor-suppressive microRNAs hold significant therapeutic potential for cancer treatment.
  • Current microRNA delivery strategies are limited by the vulnerability of microRNAs to degradation by RNases in physiological environments.
  • This degradation poses a major bottleneck for the clinical application of microRNA-based therapies.

Purpose of the Study:

  • To develop a novel DNA nanostructure for the protection and delivery of tumor-suppressive microRNAs.
  • To demonstrate the efficacy of this nanostructure in shielding microRNA-145 from RNase degradation.
  • To evaluate the therapeutic potential of protected microRNA-145 in human colorectal cancer cells.

Main Methods:

  • Design and synthesis of a programmable, self-assembled DNA nanostructure with a 'shuriken' shape.
  • Incorporation of complementary sequences within the nanostructure to hybridize with microRNA cargo.
  • In vitro assessment of microRNA protection and delivery in human colorectal cancer cells.

Main Results:

  • The DNA nanostructure successfully protected microRNA-145 from RNase degradation through steric shielding.
  • The nanostructure facilitated the delivery of microRNA-145, allowing it to exert its therapeutic effect.
  • This proof-of-concept study validates the DNA nanostructure as a protective delivery vehicle for microRNAs.

Conclusions:

  • A novel DNA nanostructure-based approach effectively protects microRNAs from degradation, addressing a critical challenge in nucleic acid delivery.
  • This 'protector' concept offers a new paradigm for exploiting tumor-suppressive microRNAs in anti-cancer therapy.
  • The developed system shows promise for advancing microRNA-based therapeutics for colorectal cancer and potentially other malignancies.

Related Concept Videos

RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K